State Of Tennessee, Treasury Department Edwards Lifesciences Corp Transaction History

State Of Tennessee, Treasury Department

$26.7 Billion
Q2 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 285,084 shares of EW stock, worth $18.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

285,084

Previous 268,970 5.99%

Holding current value

$18.7 Million

Previous $25.7 Million 2.46%

% of portfolio

0.1%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $1.36 Million - $1.52 Million	16,114 Added 5.99%	285,084 $26.3 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $1.38 Million - $1.82 Million	-19,052 Reduced 6.61%	268,970 $25.7 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $10.2 Million - $12.8 Million	-165,009 Reduced 36.42%	288,022 $22 Million
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $2.44 Million - $2.83 Million	29,963 Added 7.08%	453,031 $42.7 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $2.79 Million - $3.18 Million	37,593 Added 9.75%	423,068 $35 Million
Q4 2022 Feb 15, 2023	SELL	$68.3 - $87.44 $2.1 Million - $2.69 Million	-30,796 Reduced 7.4%	385,475 $28.8 Million
Q3 2022 Jan 26, 2023	BUY	$82.37 - $107.29 $719,666 - $937,392	8,737 Added 2.14%	416,271 $34.4 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1.95 Million - $2.89 Million	-22,497 Reduced 5.23%	407,534 $38.8 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $5.04 Million - $6.35 Million	49,456 Added 13.0%	430,031 $50.6 Million
Q4 2021 Feb 15, 2022	BUY	$106.37 - $130.68 $18.7 Million - $23 Million	175,706 Added 85.77%	380,575 $49.3 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $7.01 Million - $8.36 Million	68,109 Added 49.8%	204,869 $23.2 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $2.16 Million - $2.69 Million	25,712 Added 23.15%	136,760 $14.2 Million
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $63,416 - $73,080	-806 Reduced 0.72%	111,048 $9.29 Million
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $5.82 Million - $7.41 Million	-81,208 Reduced 42.06%	111,854 $10.2 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $51.8 Million - $67.5 Million	-771,590 Reduced 79.99%	193,062 $15.4 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $36.9 Million - $49.4 Million	642,098 Added 199.07%	964,652 $66.7 Million
Q1 2020 May 28, 2020	BUY	$52.41 - $81.0 $16.9 Million - $26.1 Million	322,554 New	322,554 $60.8 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $5.32 Million - $8.22 Million	-101,468 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $417,509 - $478,010	5,823 Added 6.09%	101,468 $23.7 Million
Q3 2019 Oct 30, 2019	BUY	$61.55 - $75.43 $1.74 Million - $2.13 Million	28,270 Added 41.96%	95,645 $21 Million
Q2 2019 Aug 12, 2019	BUY	$55.74 - $64.41 $857,782 - $991,205	15,389 Added 29.6%	67,375 $12.4 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $2.07 Million - $2.77 Million	-43,262 Reduced 45.42%	51,986 $9.95 Million
Q4 2018 Feb 11, 2019	BUY	$46.41 - $56.94 $2.25 Million - $2.76 Million	48,507 Added 103.78%	95,248 $14.6 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $6.09 Million - $7.74 Million	-133,330 Reduced 74.04%	46,741 $8.14 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $1.7 Million - $2.06 Million	40,092 Added 28.64%	180,071 $26.2 Million
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $3.17 Million - $4.04 Million	85,233 Added 155.69%	139,979 $19.5 Million
Q4 2017 Feb 12, 2018	SELL	$33.79 - $39.39 $5.15 Million - $6 Million	-152,343 Reduced 73.56%	54,746 $6.17 Million
Q3 2017 Nov 01, 2017	BUY	$36.29 - $38.83 $7.52 Million - $8.04 Million	207,089	207,089 $22.6 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Edwards Lifesciences Corp Transaction History